Pharmacology of lipoprotein receptors.
Bernini
F
F
Institute of Pharmacological Sciences, University of Milan, Italy.
Corsini
A
A
Fumagalli
R
R
Paoletti
R
R
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001647:Bile Acids and Salts / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006937:Hypercholesterolemia / Q000188:drug therapy; D007140:Immunoglobulin Fab Fragments / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000378:metabolism*; D011973:Receptors, LDL / Q000187:drug effects / Q000502:physiology*; D012867:Skin / Q000187:drug effects / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D001647:Bile Acids and Salts; D002121:Calcium Channel Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007140:Immunoglobulin Fab Fragments; D008077:Lipoproteins, LDL; D011973:Receptors, LDL